BamSEC and AlphaSense Join Forces
Learn More

STAAR Surgical Company – Material Contracts

NASDAQ: STAA    
Share price (5/5/26): $27.45    
Market cap (5/5/26): $1.367 billion
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.33
from 10-K 7 pages Consulting Agreement
12/34/56
EX-10.32
from 10-K 13 pages This Letter Agreement (This “Separation Agreement”) Formalizes Our Discussions Regarding the Terms and Conditions of Your Separation From Service With STAAR Surgical Company (The “Company”). Reference Is Made to the Severance Agreement Between You and the Company, Dated as of December 12, 2023 (The “Severance Agreement”). Capitalized Terms Used but Not Defined Herein Have the Meanings Ascribed to Such Terms in the Severance Agreement. 1. Separation From Service You Hereby Acknowledge and Agree That Your Employment With the Company Will Terminate on February 4, 2026 (The “Separation Date”). A
12/34/56
EX-10.31
from 10-K 3 pages February 1, 2026 Warren Foust C/O STAAR Surgical Company 25510 Commercentre Drive Lake Forest, California 92630 Re: Interim Co-CEO Letter Agreement Dear Warren: This Letter Agreement (“Agreement”) Sets Forth Certain Terms and Conditions of Your Appointment as Interim
12/34/56
EX-10.30
from 10-K 12 pages This Letter Agreement (This “Agreement”) Formalizes Our Discussions Regarding the Terms and Conditions of Your Separation From Service With STAAR Surgical Company (The “Company”). Reference Is Made to the Employment Agreement Between You and the Company, Effective as of February 26, 2025 (The “Employment Agreement”). Capitalized Terms Used but Not Defined Herein Have the Meanings Ascribed to Such Terms in the Employment Agreement. 1. Separation From Service
12/34/56
EX-10.1
from 8-K 9 pages January 14, 2026 Broadwood Partners, L.P. C/O Broadwood Capital, Inc. 156 West 56th Street, 3rd Floor New York, New York 10019 Re: STAAR Surgical Company Dear Mr. Bradsher
12/34/56
EX-10.2
from 10-Q 8 pages Consulting Agreement
12/34/56
EX-10.1
from 10-Q 2 pages Material contract
12/34/56
EX-10.3
from 10-Q 7 pages STAAR Surgical Company Performance Stock Unit Award Grant Notice
12/34/56
EX-10.2
from 8-K 8 pages Consulting Agreement
12/34/56
EX-10.1
from 8-K 25 pages Employment Agreement
12/34/56
EX-10.2
from 8-K 2 pages Amendment No. 1 to the Staar Surgical Company Amended and Restated Omnibus Equity Incentive Plan * * * * * I Hereby Certify That the Foregoing Amendment Was Duly Adopted by the Board of Directors of Staar Surgical Company on March 28, 2024. * * * * * I Hereby Certify That the Foregoing Amendment Was Approved by the Stockholders of Staar Surgical Company on June 20, 2024
12/34/56
EX-10.1
from 8-K 26 pages Staar Surgical Company Amended and Restated Omnibus Equity Incentive Plan Article 1. Purpose
12/34/56
EX-10.27
from 10-K 3 pages Material contract
12/34/56
EX-10.24
from 10-K 5 pages First Amendment to Lease
12/34/56
EX-10.20
from 10-K 3 pages Tenth Amendment of Lease
12/34/56
EX-10.13
from 10-K 2 pages Material contract
12/34/56
EX-10.3
from 10-K 18 pages Staar Surgical Company Change in Control Agreement
12/34/56
EX-10
from 10-Q 18 pages Staar Surgical Company Severance Agreement
12/34/56
EX-10
from 10-Q 2 pages Material contract
12/34/56
EX-10
from 8-K 2 pages Material contract
12/34/56